Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-01-19

AUTHORS

Marc Evans, Angharad R. Morgan, Stephen C. Bain, Sarah Davies, Debbie Hicks, Pam Brown, Zaheer Yousef, Umesh Dashora, Adie Viljoen, Hannah Beba, W. David Strain

ABSTRACT

While glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are among the most effective drugs for treating people with type 2 diabetes (T2D), they are clinically under-utilised. Until recently, the only route for semaglutide administration was via subcutaneous injection. However, an oral formulation of semaglutide was recently licensed, with the potential to address therapy inertia and increase patient adherence to treatment, which is essential in controlling blood glucose and reducing complications. The availability of oral semaglutide provides a new option for both clinicians and patients who are reluctant to use an injectable agent. This has been of particular importance in addressing the challenge of virtual diabetes care during the COVID-19 pandemic, circumventing the logistical problems that are often associated with subcutaneous medication administration. However, there remains limited awareness of the clinical and economic value of oral semaglutide in routine clinical practice. In this article, we present our consensus opinion on the role of oral semaglutide in routine clinical practice and discuss its value in reducing the burden of delivering diabetes care in the post-COVID-19 pandemic period of chronic disease management. More... »

PAGES

225-240

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z

DOI

http://dx.doi.org/10.1007/s13300-021-01201-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1144777213

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35044569


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/grid.273109.e", 
          "name": [
            "Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evans", 
        "givenName": "Marc", 
        "id": "sg:person.01167546340.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Economics and Outcomes Research Ltd., Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/grid.512413.0", 
          "name": [
            "Health Economics and Outcomes Research Ltd., Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morgan", 
        "givenName": "Angharad R.", 
        "id": "sg:person.015620765533.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015620765533.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Research Unit, Swansea University Medical School, Swansea, UK", 
          "id": "http://www.grid.ac/institutes/grid.4827.9", 
          "name": [
            "Diabetes Research Unit, Swansea University Medical School, Swansea, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bain", 
        "givenName": "Stephen C.", 
        "id": "sg:person.015324426577.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015324426577.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Woodlands Medical Centre, Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Woodlands Medical Centre, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davies", 
        "givenName": "Sarah", 
        "id": "sg:person.013762121575.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013762121575.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medicus Health Partners, Enfield, London, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medicus Health Partners, Enfield, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hicks", 
        "givenName": "Debbie", 
        "id": "sg:person.0604761477.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604761477.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "SA1 Medical Centre, Swansea, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "SA1 Medical Centre, Swansea, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brown", 
        "givenName": "Pam", 
        "id": "sg:person.015765201507.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015765201507.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wales Heart Research Institute, Cardiff University, Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/grid.5600.3", 
          "name": [
            "Wales Heart Research Institute, Cardiff University, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yousef", 
        "givenName": "Zaheer", 
        "id": "sg:person.01171526317.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171526317.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "East Sussex Healthcare NHS Trust, Seaford, UK", 
          "id": "http://www.grid.ac/institutes/grid.439656.b", 
          "name": [
            "East Sussex Healthcare NHS Trust, Seaford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dashora", 
        "givenName": "Umesh", 
        "id": "sg:person.01050674114.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050674114.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "East and North Hertfordshire NHS Trust, Stevenage, UK", 
          "id": "http://www.grid.ac/institutes/grid.439624.e", 
          "name": [
            "East and North Hertfordshire NHS Trust, Stevenage, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viljoen", 
        "givenName": "Adie", 
        "id": "sg:person.01312211026.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312211026.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "County Durham and Darlington NHS Foundation Trust, Durham, UK", 
          "id": "http://www.grid.ac/institutes/grid.412907.9", 
          "name": [
            "County Durham and Darlington NHS Foundation Trust, Durham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beba", 
        "givenName": "Hannah", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK", 
          "id": "http://www.grid.ac/institutes/grid.416118.b", 
          "name": [
            "Diabetes and Vascular Research Centre, University of Exeter Medical School, Exeter, UK", 
            "The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strain", 
        "givenName": "W. David", 
        "id": "sg:person.0770350302.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770350302.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13300-021-01034-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1136423665", 
          "https://doi.org/10.1007/s13300-021-01034-w"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-020-00883-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1129560870", 
          "https://doi.org/10.1007/s13300-020-00883-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12902-021-00798-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1139157917", 
          "https://doi.org/10.1186/s12902-021-00798-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-018-0649-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103179714", 
          "https://doi.org/10.1007/s40262-018-0649-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12933-015-0260-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053028267", 
          "https://doi.org/10.1186/s12933-015-0260-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-019-00736-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1123313018", 
          "https://doi.org/10.1007/s13300-019-00736-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-020-00989-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1134461617", 
          "https://doi.org/10.1007/s13300-020-00989-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrdp.2015.19", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006052568", 
          "https://doi.org/10.1038/nrdp.2015.19"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-01-19", 
    "datePublishedReg": "2022-01-19", 
    "description": "While glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are among the most effective drugs for treating people with type 2 diabetes (T2D), they are clinically under-utilised. Until recently, the only route for semaglutide administration was via subcutaneous injection. However, an oral formulation of semaglutide was recently licensed, with the potential to address therapy inertia and increase patient adherence to treatment, which is essential in controlling blood glucose and reducing complications. The availability of oral semaglutide provides a new option for both clinicians and patients who are reluctant to use an injectable agent. This has been of particular importance in addressing the challenge of virtual diabetes care during the COVID-19 pandemic, circumventing the logistical problems that are often associated with subcutaneous medication administration. However, there remains limited awareness of the clinical and economic value of oral semaglutide in routine clinical practice. In this article, we present our consensus opinion on the role of oral semaglutide in routine clinical practice and discuss its value in reducing the burden of delivering diabetes care in the post-COVID-19 pandemic period of chronic disease management.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13300-021-01201-z", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "routine clinical practice", 
      "oral semaglutide", 
      "diabetes care", 
      "clinical practice", 
      "glucagon-like peptide-1 receptor agonists", 
      "peptide-1 receptor agonists", 
      "type 2 diabetes", 
      "chronic disease management", 
      "patient adherence", 
      "receptor agonist", 
      "blood glucose", 
      "subcutaneous injection", 
      "medication administration", 
      "injectable agents", 
      "oral formulation", 
      "effective drugs", 
      "semaglutide", 
      "consensus opinion", 
      "disease management", 
      "care", 
      "COVID-19 pandemic", 
      "consensus viewpoint", 
      "administration", 
      "new options", 
      "limited awareness", 
      "pandemic period", 
      "complications", 
      "diabetes", 
      "patients", 
      "agonists", 
      "clinicians", 
      "drugs", 
      "adherence", 
      "logistical problems", 
      "treatment", 
      "injection", 
      "burden", 
      "glucose", 
      "only route", 
      "practice", 
      "pandemic", 
      "options", 
      "agents", 
      "particular importance", 
      "management", 
      "period", 
      "role", 
      "awareness", 
      "people", 
      "challenges", 
      "values", 
      "opinion", 
      "potential", 
      "importance", 
      "positioning", 
      "route", 
      "availability", 
      "article", 
      "formulation", 
      "problem", 
      "viewpoint", 
      "economic value", 
      "inertia"
    ], 
    "name": "Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice", 
    "pagination": "225-240", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1144777213"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-021-01201-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35044569"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-021-01201-z", 
      "https://app.dimensions.ai/details/publication/pub.1144777213"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_936.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13300-021-01201-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      95 URIs      79 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-021-01201-z schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N17be2b43a3b442dea71c867f4acfc066
4 schema:citation sg:pub.10.1007/s13300-019-00736-6
5 sg:pub.10.1007/s13300-020-00883-1
6 sg:pub.10.1007/s13300-020-00989-6
7 sg:pub.10.1007/s13300-021-01034-w
8 sg:pub.10.1007/s40262-018-0649-2
9 sg:pub.10.1038/nrdp.2015.19
10 sg:pub.10.1186/s12902-021-00798-3
11 sg:pub.10.1186/s12933-015-0260-x
12 schema:datePublished 2022-01-19
13 schema:datePublishedReg 2022-01-19
14 schema:description While glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are among the most effective drugs for treating people with type 2 diabetes (T2D), they are clinically under-utilised. Until recently, the only route for semaglutide administration was via subcutaneous injection. However, an oral formulation of semaglutide was recently licensed, with the potential to address therapy inertia and increase patient adherence to treatment, which is essential in controlling blood glucose and reducing complications. The availability of oral semaglutide provides a new option for both clinicians and patients who are reluctant to use an injectable agent. This has been of particular importance in addressing the challenge of virtual diabetes care during the COVID-19 pandemic, circumventing the logistical problems that are often associated with subcutaneous medication administration. However, there remains limited awareness of the clinical and economic value of oral semaglutide in routine clinical practice. In this article, we present our consensus opinion on the role of oral semaglutide in routine clinical practice and discuss its value in reducing the burden of delivering diabetes care in the post-COVID-19 pandemic period of chronic disease management.
15 schema:genre article
16 schema:isAccessibleForFree true
17 schema:isPartOf N072a13a3f8454d16889a9e8ac69b9a47
18 Nde838d87c6f24ce2a079ab2655a4b1f9
19 sg:journal.1044057
20 schema:keywords COVID-19 pandemic
21 adherence
22 administration
23 agents
24 agonists
25 article
26 availability
27 awareness
28 blood glucose
29 burden
30 care
31 challenges
32 chronic disease management
33 clinical practice
34 clinicians
35 complications
36 consensus opinion
37 consensus viewpoint
38 diabetes
39 diabetes care
40 disease management
41 drugs
42 economic value
43 effective drugs
44 formulation
45 glucagon-like peptide-1 receptor agonists
46 glucose
47 importance
48 inertia
49 injectable agents
50 injection
51 limited awareness
52 logistical problems
53 management
54 medication administration
55 new options
56 only route
57 opinion
58 options
59 oral formulation
60 oral semaglutide
61 pandemic
62 pandemic period
63 particular importance
64 patient adherence
65 patients
66 people
67 peptide-1 receptor agonists
68 period
69 positioning
70 potential
71 practice
72 problem
73 receptor agonist
74 role
75 route
76 routine clinical practice
77 semaglutide
78 subcutaneous injection
79 treatment
80 type 2 diabetes
81 values
82 viewpoint
83 schema:name Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice
84 schema:pagination 225-240
85 schema:productId N74497c1b9ff847ea9f2b4ce7c6a1102f
86 Nd2fc10e52a7c4d139fe7baf4bb2cc282
87 Ndddb132affed4c09a25d9b7379daa334
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1144777213
89 https://doi.org/10.1007/s13300-021-01201-z
90 schema:sdDatePublished 2022-10-01T06:50
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher Nd52b6f2f334d4f99bc726b52428cacdb
93 schema:url https://doi.org/10.1007/s13300-021-01201-z
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N072a13a3f8454d16889a9e8ac69b9a47 schema:volumeNumber 13
98 rdf:type schema:PublicationVolume
99 N0bb97ec958094f698c7cba5abbf796f9 rdf:first sg:person.0604761477.76
100 rdf:rest N30a06cdda0f54c579d10c37433d4f3bb
101 N13dcc6b8ecf544fe864af3eb41a325a1 rdf:first sg:person.01171526317.16
102 rdf:rest N9cc62f04678345378b0e052d741b97d1
103 N17be2b43a3b442dea71c867f4acfc066 rdf:first sg:person.01167546340.80
104 rdf:rest N8a3891a33e8741628e97d2f9658bef99
105 N26c6cec7c2b24e169171859f201db0a1 schema:affiliation grid-institutes:grid.412907.9
106 schema:familyName Beba
107 schema:givenName Hannah
108 rdf:type schema:Person
109 N30a06cdda0f54c579d10c37433d4f3bb rdf:first sg:person.015765201507.16
110 rdf:rest N13dcc6b8ecf544fe864af3eb41a325a1
111 N74497c1b9ff847ea9f2b4ce7c6a1102f schema:name dimensions_id
112 schema:value pub.1144777213
113 rdf:type schema:PropertyValue
114 N8a3891a33e8741628e97d2f9658bef99 rdf:first sg:person.015620765533.24
115 rdf:rest Nfb09a710e59148b986bc390f57f6d8b3
116 N9cc62f04678345378b0e052d741b97d1 rdf:first sg:person.01050674114.03
117 rdf:rest Nd146f162d0e34d5ba19dea3254d40fce
118 Nbc7f626000f84664a1ef6a367ebb8bd8 rdf:first N26c6cec7c2b24e169171859f201db0a1
119 rdf:rest Nd138c0fbd6a24faca2dba3ad8770e0dc
120 Ncd84021b669a41079f3eaabd55501ab1 rdf:first sg:person.013762121575.87
121 rdf:rest N0bb97ec958094f698c7cba5abbf796f9
122 Nd138c0fbd6a24faca2dba3ad8770e0dc rdf:first sg:person.0770350302.52
123 rdf:rest rdf:nil
124 Nd146f162d0e34d5ba19dea3254d40fce rdf:first sg:person.01312211026.59
125 rdf:rest Nbc7f626000f84664a1ef6a367ebb8bd8
126 Nd2fc10e52a7c4d139fe7baf4bb2cc282 schema:name doi
127 schema:value 10.1007/s13300-021-01201-z
128 rdf:type schema:PropertyValue
129 Nd52b6f2f334d4f99bc726b52428cacdb schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 Ndddb132affed4c09a25d9b7379daa334 schema:name pubmed_id
132 schema:value 35044569
133 rdf:type schema:PropertyValue
134 Nde838d87c6f24ce2a079ab2655a4b1f9 schema:issueNumber 2
135 rdf:type schema:PublicationIssue
136 Nfb09a710e59148b986bc390f57f6d8b3 rdf:first sg:person.015324426577.19
137 rdf:rest Ncd84021b669a41079f3eaabd55501ab1
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
142 schema:name Clinical Sciences
143 rdf:type schema:DefinedTerm
144 sg:journal.1044057 schema:issn 1869-6953
145 1869-6961
146 schema:name Diabetes Therapy
147 schema:publisher Springer Nature
148 rdf:type schema:Periodical
149 sg:person.01050674114.03 schema:affiliation grid-institutes:grid.439656.b
150 schema:familyName Dashora
151 schema:givenName Umesh
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050674114.03
153 rdf:type schema:Person
154 sg:person.01167546340.80 schema:affiliation grid-institutes:grid.273109.e
155 schema:familyName Evans
156 schema:givenName Marc
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80
158 rdf:type schema:Person
159 sg:person.01171526317.16 schema:affiliation grid-institutes:grid.5600.3
160 schema:familyName Yousef
161 schema:givenName Zaheer
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171526317.16
163 rdf:type schema:Person
164 sg:person.01312211026.59 schema:affiliation grid-institutes:grid.439624.e
165 schema:familyName Viljoen
166 schema:givenName Adie
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312211026.59
168 rdf:type schema:Person
169 sg:person.013762121575.87 schema:affiliation grid-institutes:None
170 schema:familyName Davies
171 schema:givenName Sarah
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013762121575.87
173 rdf:type schema:Person
174 sg:person.015324426577.19 schema:affiliation grid-institutes:grid.4827.9
175 schema:familyName Bain
176 schema:givenName Stephen C.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015324426577.19
178 rdf:type schema:Person
179 sg:person.015620765533.24 schema:affiliation grid-institutes:grid.512413.0
180 schema:familyName Morgan
181 schema:givenName Angharad R.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015620765533.24
183 rdf:type schema:Person
184 sg:person.015765201507.16 schema:affiliation grid-institutes:None
185 schema:familyName Brown
186 schema:givenName Pam
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015765201507.16
188 rdf:type schema:Person
189 sg:person.0604761477.76 schema:affiliation grid-institutes:None
190 schema:familyName Hicks
191 schema:givenName Debbie
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604761477.76
193 rdf:type schema:Person
194 sg:person.0770350302.52 schema:affiliation grid-institutes:grid.416118.b
195 schema:familyName Strain
196 schema:givenName W. David
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770350302.52
198 rdf:type schema:Person
199 sg:pub.10.1007/s13300-019-00736-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1123313018
200 https://doi.org/10.1007/s13300-019-00736-6
201 rdf:type schema:CreativeWork
202 sg:pub.10.1007/s13300-020-00883-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129560870
203 https://doi.org/10.1007/s13300-020-00883-1
204 rdf:type schema:CreativeWork
205 sg:pub.10.1007/s13300-020-00989-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134461617
206 https://doi.org/10.1007/s13300-020-00989-6
207 rdf:type schema:CreativeWork
208 sg:pub.10.1007/s13300-021-01034-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1136423665
209 https://doi.org/10.1007/s13300-021-01034-w
210 rdf:type schema:CreativeWork
211 sg:pub.10.1007/s40262-018-0649-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103179714
212 https://doi.org/10.1007/s40262-018-0649-2
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/nrdp.2015.19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006052568
215 https://doi.org/10.1038/nrdp.2015.19
216 rdf:type schema:CreativeWork
217 sg:pub.10.1186/s12902-021-00798-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1139157917
218 https://doi.org/10.1186/s12902-021-00798-3
219 rdf:type schema:CreativeWork
220 sg:pub.10.1186/s12933-015-0260-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053028267
221 https://doi.org/10.1186/s12933-015-0260-x
222 rdf:type schema:CreativeWork
223 grid-institutes:None schema:alternateName Medicus Health Partners, Enfield, London, UK
224 SA1 Medical Centre, Swansea, UK
225 Woodlands Medical Centre, Cardiff, UK
226 schema:name Medicus Health Partners, Enfield, London, UK
227 SA1 Medical Centre, Swansea, UK
228 Woodlands Medical Centre, Cardiff, UK
229 rdf:type schema:Organization
230 grid-institutes:grid.273109.e schema:alternateName Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK
231 schema:name Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK
232 rdf:type schema:Organization
233 grid-institutes:grid.412907.9 schema:alternateName County Durham and Darlington NHS Foundation Trust, Durham, UK
234 schema:name County Durham and Darlington NHS Foundation Trust, Durham, UK
235 rdf:type schema:Organization
236 grid-institutes:grid.416118.b schema:alternateName The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK
237 schema:name Diabetes and Vascular Research Centre, University of Exeter Medical School, Exeter, UK
238 The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK
239 rdf:type schema:Organization
240 grid-institutes:grid.439624.e schema:alternateName East and North Hertfordshire NHS Trust, Stevenage, UK
241 schema:name East and North Hertfordshire NHS Trust, Stevenage, UK
242 rdf:type schema:Organization
243 grid-institutes:grid.439656.b schema:alternateName East Sussex Healthcare NHS Trust, Seaford, UK
244 schema:name East Sussex Healthcare NHS Trust, Seaford, UK
245 rdf:type schema:Organization
246 grid-institutes:grid.4827.9 schema:alternateName Diabetes Research Unit, Swansea University Medical School, Swansea, UK
247 schema:name Diabetes Research Unit, Swansea University Medical School, Swansea, UK
248 rdf:type schema:Organization
249 grid-institutes:grid.512413.0 schema:alternateName Health Economics and Outcomes Research Ltd., Cardiff, UK
250 schema:name Health Economics and Outcomes Research Ltd., Cardiff, UK
251 rdf:type schema:Organization
252 grid-institutes:grid.5600.3 schema:alternateName Wales Heart Research Institute, Cardiff University, Cardiff, UK
253 schema:name Wales Heart Research Institute, Cardiff University, Cardiff, UK
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...